U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866833) titled 'Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)' on Sept. 23.
Brief Summary: This study tested whether intravenous methylene blue changes brain activity during a working-memory task differently in adults with schizophrenia taking stable antipsychotic medication and healthy volunteers. Each participant received methylene blue and a placebo solution with no methylene blue at separate visits and completed the task during functional magnetic resonance imaging (fMRI)
Study Start Date: June 01, 2020
Study Type: INTERVENTIONAL
Condition:
Schizophrenia and Other Psychotic Disorders
Healthy Adult
Intervention:
D...